Search these posts for articles, publications, research studies & discussions relevant to Phoenix Technology Group products.

Research Blog

2017

Micron Retinal Imaging System Provides Ground Breaking Research on Parkinson’s Disease

Phoenix Research Labs is pleased to announce ground breaking research on Parkinson’s Disease by Price et al using the Micron Retinal Imaging System.  Abnormally high concentration of the protein a-synuclein in the brain is linked with the physical and mental deficits caused by Parkinson’s Disease {PD) and Dementia with Lewy Bodies (DLP). 

2017

Analyzing Choroidal Neovascularization (CNV) in pigs: Saline vs. Eylea™

In the experiment above, pigs received six laser shots per eye, with the control group receiving saline treatment and test group receiving Eylea™ treatment.  Eylea™, an FDA-approved drug, is an anti-vascular endothelial growth factor (anti-VEGF) that prevents vascular growth.  The crisp, high resoution brightfield and fluorescein angiography images, captured by the Micron X, show that Eylea™ clearly mitigates the neovascularization induced by laser burn.

2016

Detection of Infectious Diseases in the Retina of Mice

A poster presentation by Emily Gordon, et al., from the National Institute of Allergy and Infectious Diseases revealed the observation of cerebral malaria in the mouse retina as imaged by the Phoenix Research Labs retinal camera the Micron IV.
According to the authors “Microcirculation in the retinal vasculature provides a window to image dynamic changes taking place in the central nervous system during CM disease progression.

1 3 4 5